AI assistant
GENETIC TECHNOLOGIES LIMITED — Board/Management Information 2012
Nov 26, 2012
65022_rns_2012-11-26_18085055-d435-46a2-9539-fa760e5c4d15.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [592 x 69] intentionally omitted <==
==> picture [592 x 69] intentionally omitted <==
ASX ANNOUNCEMENT November 27[th] , 2012
Resignations
Following today’s Annual General Meeting in Melbourne, the Board of Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) announces the outcome of the AGM - directors Dr. Mel Bridges and Mr. Huw Jones will be leaving the Board, and Mr. Greg Brown has resigned effective November 27[th] , 2012.
The Board also announces the immediate resignation of Dr. Paul MacLeman as CEO and also accepts the resignation of Dr. David Sparling, VP Legal and Corporate Development.
Dr. Bridges said it is regrettable that a company with the potential of GTG was unable to reach middle ground with its major shareholder.
Genetic Technologies Limited (ABN 17 009 212 328) Phone: +61 3 8412 7000
Genetic Technologies Limited • Website : www.gtglabs.com • Email : [email protected] ABN 17 009 212 328 Registered Office • 60-66 Hanover Street Fitzroy Victoria 3065 Australia • Postal Address P.O. Box 115 Fitzroy Victoria 3065 Australia Phone +61 3 8412 7000 • Fax +61 3 8412 7040